• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险理赔与肿瘤登记数据在癌症相关治疗评估方面的一致性。

Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.

作者信息

Cooper G S, Yuan Z, Stange K C, Dennis L K, Amini S B, Rimm A A

机构信息

Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

Med Care. 2000 Apr;38(4):411-21. doi: 10.1097/00005650-200004000-00008.

DOI:10.1097/00005650-200004000-00008
PMID:10752973
Abstract

BACKGROUND

Although health claims data are increasingly used in evaluating variations in patterns of cancer care and outcomes, little is known about the comparability of these data with tumor registry information.

OBJECTIVES

To evaluate the agreement between Medicare claims and tumor registry data in measuring patterns of diagnostic and therapeutic procedures for older cancer patients.

RESEARCH DESIGN

Analysis of a database linking Surveillance, Epidemiology and End Results (SEER) registry data and Medicare claims in patients aged > or =65 years with cancer.

SUBJECTS

361,255 Medicare patients with invasive breast, colorectal, endometrial, lung, pancreatic, and prostate cancer diagnosed between 1984 and 1993.

MEASURES

Concordance of SEER files with corresponding Medicare claims.

RESULTS

Medicare claims generally identified patients who underwent resection and radical surgery according to SEER (ie, concordance > or =85%-90%) but less likely biopsy or local excision (ie, concordance < or =50%). In some instances, claims also categorized patients as having more invasive surgery than was listed in SEER and also provided incremental information about the use of surgical treatment after 4 months. SEER files and, to a lesser degree, Medicare claims identified radiation therapy not included in the other data source, and Medicare files also captured a significant number of patients with codes for chemotherapy.

CONCLUSIONS

Medicare files may be appropriate for studies of patterns of use of surgical treatment, but not for diagnostic procedures. The potential benefit of Medicare claims in identifying delayed surgical intervention and chemotherapy deserves further study.

摘要

背景

尽管健康声明数据越来越多地用于评估癌症治疗模式和结果的差异,但对于这些数据与肿瘤登记信息的可比性知之甚少。

目的

评估医疗保险声明与肿瘤登记数据在测量老年癌症患者诊断和治疗程序模式方面的一致性。

研究设计

对一个数据库进行分析,该数据库将监测、流行病学和最终结果(SEER)登记数据与年龄≥65岁的癌症患者的医疗保险声明相链接。

研究对象

1984年至1993年间诊断为浸润性乳腺癌、结直肠癌、子宫内膜癌、肺癌、胰腺癌和前列腺癌的361,255名医疗保险患者。

测量指标

SEER文件与相应医疗保险声明的一致性。

结果

医疗保险声明通常能识别出根据SEER进行了切除和根治性手术的患者(即一致性≥85%-90%),但识别活检或局部切除患者的可能性较小(即一致性≤50%)。在某些情况下,声明还将患者分类为接受了比SEER列出的更具侵入性的手术,并且还提供了4个月后手术治疗使用情况的增量信息。SEER文件以及在较小程度上医疗保险声明识别出了其他数据源未包括的放射治疗,医疗保险文件还记录了大量有化疗代码的患者。

结论

医疗保险文件可能适用于手术治疗使用模式的研究,但不适用于诊断程序。医疗保险声明在识别延迟手术干预和化疗方面的潜在益处值得进一步研究。

相似文献

1
Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.医疗保险理赔与肿瘤登记数据在癌症相关治疗评估方面的一致性。
Med Care. 2000 Apr;38(4):411-21. doi: 10.1097/00005650-200004000-00008.
2
Use of SEER-Medicare data for measuring cancer surgery.利用监测、流行病学与最终结果(SEER)-医疗保险数据来衡量癌症手术情况。
Med Care. 2002 Aug;40(8 Suppl):IV-43-8. doi: 10.1097/00005650-200208001-00006.
3
The utility of Medicare claims data for measuring cancer stage.医疗保险理赔数据在测量癌症分期方面的效用。
Med Care. 1999 Jul;37(7):706-11. doi: 10.1097/00005650-199907000-00010.
4
Construct validity of medicare chemotherapy claims: the case of 5FU.医疗保险化疗报销申请的结构效度:以5-氟尿嘧啶为例。
Med Care. 2002 Mar;40(3):201-11. doi: 10.1097/00005650-200203000-00004.
5
Studying radiation therapy using SEER-Medicare-linked data.利用与监测、流行病学和最终结果(SEER)计划及医疗保险相关联的数据研究放射治疗。
Med Care. 2002 Aug;40(8 Suppl):IV-49-54. doi: 10.1097/00005650-200208001-00007.
6
Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.国家癌症数据库与监测、流行病学和最终结果-医疗保险数据库中合并症的比较。
Ann Surg Oncol. 2016 Dec;23(13):4139-4148. doi: 10.1245/s10434-016-5508-5. Epub 2016 Aug 17.
7
Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.医疗保险索赔中诊断代码对识别癌症转移和推断分期的有效性有限。
Ann Epidemiol. 2014 Sep;24(9):666-72, 672.e1-2. doi: 10.1016/j.annepidem.2014.06.099. Epub 2014 Jul 3.
8
Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.SEER 与医疗保险索赔数据的诊断日期一致性:对治疗的影响。
Med Care. 2014 Jan;52(1):32-7. doi: 10.1097/MLR.0000000000000004.
9
Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.行政索赔与登记数据在识别前列腺癌骨转移中的一致性:一项探索性分析。
BMC Med Res Methodol. 2014 Jan 2;14:1. doi: 10.1186/1471-2288-14-1.
10
Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.医疗保险乳腺癌手术治疗理赔数据的准确性和完整性。
Med Care. 2000 Jul;38(7):719-27. doi: 10.1097/00005650-200007000-00004.

引用本文的文献

1
Consistency Between State's Cancer Registry and All-Payer Claims Database in Documented Radiation Therapy Among Patients Who Received Breast Conservative Surgery.国家癌症登记处与所有支付方索赔数据库在接受保乳手术患者的记录放疗方面的一致性。
JCO Clin Cancer Inform. 2023 Jan;7:e2200099. doi: 10.1200/CCI.22.00099.
2
Cancer Treatment Data in Central Cancer Registries: When Are Supplemental Data Needed?中央癌症登记处的癌症治疗数据:何时需要补充数据?
Cancer Inform. 2022 Jul 30;21:11769351221112457. doi: 10.1177/11769351221112457. eCollection 2022.
3
Breast Cancer Treatment Following Health Reform: Evidence From Massachusetts.
医疗改革后乳腺癌的治疗:来自马萨诸塞州的证据。
Med Care Res Rev. 2022 Jun;79(3):371-381. doi: 10.1177/10775587211042532. Epub 2021 Sep 1.
4
Assessment of Oncology Practice Billing Claims for Supplementing Chemotherapy: A Pilot Study in the Georgia SEER Cancer Registry.评估肿瘤学实践补充化疗计费主张:佐治亚州 SEER 癌症登记处的一项试点研究。
J Natl Cancer Inst Monogr. 2020 May 1;2020(55):82-88. doi: 10.1093/jncimonographs/lgaa006.
5
Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.局部晚期下咽癌的治疗顺序与生存:基于监测、流行病学和最终结果的研究。
Laryngoscope. 2020 Nov;130(11):2611-2621. doi: 10.1002/lary.28452. Epub 2019 Dec 10.
6
The opportunities and shortcomings of using big data and national databases for sarcoma research.利用大数据和国家数据库进行肉瘤研究的机遇和局限性。
Cancer. 2019 Sep 1;125(17):2926-2934. doi: 10.1002/cncr.32118. Epub 2019 May 15.
7
Persistence of racial disparities in early-stage lung cancer treatment.早期肺癌治疗中种族差异的持续存在。
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1670-1679.e4. doi: 10.1016/j.jtcvs.2018.11.108. Epub 2018 Dec 11.
8
Measuring colorectal cancer incidence: the performance of an algorithm using administrative health data.测量结直肠癌发病率:使用行政健康数据的算法性能。
BMC Med Res Methodol. 2018 May 8;18(1):38. doi: 10.1186/s12874-018-0494-x.
9
The Hawthorne effect in direct observation research with physicians and patients.医生与患者直接观察研究中的霍桑效应
J Eval Clin Pract. 2017 Dec;23(6):1322-1328. doi: 10.1111/jep.12781. Epub 2017 Jul 28.
10
Hospitalizations in Pediatric and Adult Patients for All Cancer Type in Italy: The EPIKIT Study under the E.U. COHEIRS Project on Environment and Health.意大利儿童和成人所有癌症类型的住院情况:欧盟环境与健康COHEIRS项目下的EPIKIT研究
Int J Environ Res Public Health. 2017 May 9;14(5):495. doi: 10.3390/ijerph14050495.